NCT01336569View on ClinicalTrials.gov

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Glaucoma
Interventions
DRUG

Travoprost 0.004%/timolol maleate 0.5% fixed combination

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01336569 - Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol | Biotech Hunter | Biotech Hunter